WE-G-BRF-04: Robust Real-Time Volumetric Imaging Based On One Single Projection




Real-time volumetric imaging is highly desirable to provide instantaneous image guidance for lung radiation therapy. This study proposes a scheme to achieve this goal using one single projection by utilizing sparse learning and a principal component analysis (PCA) based lung motion model.


A patient-specific PCA-based lung motion model is first constructed by analyzing deformable vector fields (DVFs) between a reference image and 4DCT images at each phase. At the training stage, we “learn” the relationship between the DVFs and the projection using sparse learning. Specifically, we first partition the projections into patches, and then apply sparse learning to automatically identify patches that best correlate with the principal components of the DVFs. Once the relationship is established, at the application stage, we first employ a patchbased intensity correction method to overcome the problem of different intensity scale between the calculated projection in the training stage and the measured projection in the application stage. The corrected projection image is then fed to the trained model to derive a DVF, which is applied to the reference image, yielding a volumetric image corresponding to the projection. We have validated our method through a NCAT phantom simulation case and one experiment case.


Sparse learning can automatically select those patches containing motion information, such as those around diaphragm. For the simulation case, over 98% of the lung region pass the generalized gamma test (10HU/1mm), indicating combined accuracy in both intensity and spatial domain. For the experimental case, the average tumor localization errors projected to the imager are 0.68 mm and 0.4 mm on the axial and tangential direction, respectively.


The proposed method is capable of accurately generating a volumetric image using one single projection. It will potentially offer real-time volumetric image guidance to facilitate lung radiotherapy.

This study is supported in part by NIH (1R01CA154747-01), The Core Technology Research in Strategic Emerging Industry, Guangdong, China(2011A081402003)